ES2066721A1 - Nuevos compuestos derivados de la piridina 1,4-disustituida. - Google Patents

Nuevos compuestos derivados de la piridina 1,4-disustituida.

Info

Publication number
ES2066721A1
ES2066721A1 ES09301062A ES9301062A ES2066721A1 ES 2066721 A1 ES2066721 A1 ES 2066721A1 ES 09301062 A ES09301062 A ES 09301062A ES 9301062 A ES9301062 A ES 9301062A ES 2066721 A1 ES2066721 A1 ES 2066721A1
Authority
ES
Spain
Prior art keywords
fluorophenylmethyl
piperidines
sigma
receptor affinity
methoxymethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301062A
Other languages
English (en)
Other versions
ES2066721B1 (es
Inventor
Ambros Rafael Foguet
Gener Jordi Bolos
Mu Oz Aurelio Sacristan
Hernandez Jose A Ortiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Priority to ES09301062A priority Critical patent/ES2066721B1/es
Priority to TW083103579A priority patent/TW252975B/zh
Priority to ZA943036A priority patent/ZA943036B/xx
Priority to EP94917641A priority patent/EP0651744A1/en
Priority to KR1019950700196A priority patent/KR950702535A/ko
Priority to AU69284/94A priority patent/AU675332B2/en
Priority to PCT/EP1994/001594 priority patent/WO1994026712A1/en
Priority to CA002140260A priority patent/CA2140260A1/en
Priority to NZ267100A priority patent/NZ267100A/en
Priority to JP6524990A priority patent/JPH07509255A/ja
Priority to NO950062A priority patent/NO301638B1/no
Priority to FI950197A priority patent/FI950197A0/fi
Publication of ES2066721A1 publication Critical patent/ES2066721A1/es
Application granted granted Critical
Publication of ES2066721B1 publication Critical patent/ES2066721B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

NUEVOS COMPUESTOS DERIVADOS DE LA PIPERIDINA 1,4-DISUSTITUIDA. CONSISTE EN LOS NUEVOS COMPUESTOS DERIVADOS DE LA PIPERIDINA 1,4-DISUSTITUIDA, DE FORMULA GENERAL (I): *FIG* DONDE X ES HIDROXIMETILEN O METOXIMETILEN, Y ES UNA SECUENCIA METILENICA DE TRES MIEMBROS Y R ES UN RESTO P-FLUOROFENIL, ASI COMO SUS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES. ESTOS COMPUESTOS SON DE USO POTENCIAL PARA TRATAR ENFERMEDADES DEL SISTEMA NERVIOSO SOMETIDAS A CONTROL DE LOS RECEPTORES {SI.
ES09301062A 1993-05-18 1993-05-18 Nuevos compuestos derivados de la piridina 1,4-disustituida. Expired - Fee Related ES2066721B1 (es)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES09301062A ES2066721B1 (es) 1993-05-18 1993-05-18 Nuevos compuestos derivados de la piridina 1,4-disustituida.
TW083103579A TW252975B (es) 1993-05-18 1994-04-22
ZA943036A ZA943036B (en) 1993-05-18 1994-05-03 1,4-disubstituted piperidine derivative compounds
PCT/EP1994/001594 WO1994026712A1 (en) 1993-05-18 1994-05-17 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity
KR1019950700196A KR950702535A (ko) 1993-05-18 1994-05-17 시그마 및 d₂-수용체 친화성을 가진 4-(4-플루오로페닐메틸)-피페리딘(4-(4-fluorophenylmethyl)-piperidines having sigma and d2-peceptor affinity)
AU69284/94A AU675332B2 (en) 1993-05-18 1994-05-17 4-(4-fluorophenylmethyl)-piperidines having sigma and D2-receptor affinity
EP94917641A EP0651744A1 (en) 1993-05-18 1994-05-17 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity
CA002140260A CA2140260A1 (en) 1993-05-18 1994-05-17 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity
NZ267100A NZ267100A (en) 1993-05-18 1994-05-17 4-[4-fluorophenyl({hydroxy or methoxy} methyl)]-1-(4-fluorophenyloxypropyl) piperidine, and pharmaceutical compositions
JP6524990A JPH07509255A (ja) 1993-05-18 1994-05-17 シグマレセプター及びｄ↓２レセプター親和性を有する４−（４−フルオロフェニルメチル）−ピペリジン
NO950062A NO301638B1 (no) 1993-05-18 1995-01-06 4-(4-fluorfenylmetyl)-piperidiner med sigma- og D2-reseptoraffinitet og deres anvendelse
FI950197A FI950197A0 (fi) 1993-05-18 1995-01-17 4-(4-fluorofenyylimetyyli)-piperidiini, jolla on sigma ja D2-reseptori affiniteetti

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09301062A ES2066721B1 (es) 1993-05-18 1993-05-18 Nuevos compuestos derivados de la piridina 1,4-disustituida.

Publications (2)

Publication Number Publication Date
ES2066721A1 true ES2066721A1 (es) 1995-03-01
ES2066721B1 ES2066721B1 (es) 1996-02-16

Family

ID=8281846

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09301062A Expired - Fee Related ES2066721B1 (es) 1993-05-18 1993-05-18 Nuevos compuestos derivados de la piridina 1,4-disustituida.

Country Status (12)

Country Link
EP (1) EP0651744A1 (es)
JP (1) JPH07509255A (es)
KR (1) KR950702535A (es)
AU (1) AU675332B2 (es)
CA (1) CA2140260A1 (es)
ES (1) ES2066721B1 (es)
FI (1) FI950197A0 (es)
NO (1) NO301638B1 (es)
NZ (1) NZ267100A (es)
TW (1) TW252975B (es)
WO (1) WO1994026712A1 (es)
ZA (1) ZA943036B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1999000149A (es) 1998-09-09 2000-01-12 Pfizer Prod Inc Derivados de 4,4-biarilpiperidina

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2237633A1 (es) * 1973-07-19 1975-02-14 Robins Co Inc A H
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
EP0229391A1 (en) * 1985-12-27 1987-07-22 Eisai Co., Ltd. Piperidine derivate, its use and pharmaceutical composition containing it
FR2681319A1 (fr) * 1991-09-12 1993-03-19 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
EP0572952A1 (en) * 1992-06-04 1993-12-08 Ferrer Internacional, S.A. 4-Benzylpiperidine derivatives, a process for preparing them and pharmaceutical compositions containing them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2237633A1 (es) * 1973-07-19 1975-02-14 Robins Co Inc A H
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
EP0229391A1 (en) * 1985-12-27 1987-07-22 Eisai Co., Ltd. Piperidine derivate, its use and pharmaceutical composition containing it
FR2681319A1 (fr) * 1991-09-12 1993-03-19 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
EP0572952A1 (en) * 1992-06-04 1993-12-08 Ferrer Internacional, S.A. 4-Benzylpiperidine derivatives, a process for preparing them and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1994026712A1 (en) 1994-11-24
NZ267100A (en) 1996-09-25
AU675332B2 (en) 1997-01-30
FI950197A (fi) 1995-01-17
ES2066721B1 (es) 1996-02-16
TW252975B (es) 1995-08-01
AU6928494A (en) 1994-12-12
CA2140260A1 (en) 1994-11-24
FI950197A0 (fi) 1995-01-17
NO950062L (no) 1995-01-06
KR950702535A (ko) 1995-07-29
EP0651744A1 (en) 1995-05-10
ZA943036B (en) 1995-05-02
NO301638B1 (no) 1997-11-24
NO950062D0 (no) 1995-01-06
JPH07509255A (ja) 1995-10-12

Similar Documents

Publication Publication Date Title
AU6690686A (en) Piperdine derivative and pharmaceutical composition
MX9701679A (es) Derivados de piperidina como antagonistas de la neuroquinina.
DE69709938D1 (de) N-benzylpiperidin- und tetrahydropyridin-derivate
MX9707879A (es) Derivados de piperazina sustituidos novedosos que tienen actividad antagonista de receptor de taquinina.
PT1158973E (pt) Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
CY2488B1 (en) New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for trea.
CA2011587A1 (en) Nerve growth factor secretion inducing composition
NO944911L (no) Ikke-peptid-takykininreseptorantagonister
NO973635L (no) Fremgangsmåte for hemming av celle-celle adhesjon
EP0378518A3 (en) Adenosine derivatives having pharmaceutical activity as antihypertensives
AU562789B2 (en) Anorexigenic trifluoromethylphenyl tetrahydropyridines
BG102015A (en) Azacycloalkane derivatives, their preparation and application in therapy
ES2066721A1 (es) Nuevos compuestos derivados de la piridina 1,4-disustituida.
TW226015B (es)
EP0659762A3 (en) Amides of sialic acid with 3-amino sterol derivatives.
IE901314L (en) 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines
HUT75647A (en) Imidazolidinone derivatives and pharmaceutical compositions containing them, which are suitable for treament of senile dementia
CA2163253A1 (en) N-p-halobenzoylmethyl derivatives of 4-(p-fluorophenyl)-3-¬¬3,4-methylenedioxy)phenoxy|methyl|piperidine
NO904135D0 (no) Fremgangsmaate for fremstilling av nye alkylpiperidiner.
NO981578L (no) FremgangsmÕte for hemming av plasminogenaktivatorhemmer I
EP0414903A4 (en) New thioproline derivative
SG48784A1 (en) Use of tetrahydropyridine derivatives for the preparation of cardioprotective medicaments
FR2626470B1 (fr) Depresseur de l'inhibiteur de l'(alpha)2-plasmine
DE69212860D1 (de) Alpha-Methylencyclopentanon-Derivate und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201